Skip to main content
xYOU DESERVE INDEPENDENT, CRITICAL MEDIA. We want readers like you. Support independent critical media.

Drug Design Today: Large Molecules or Small Molecules?

Interview with Satyajit Rath |
Interviewed by Prabir Purkayastha
Produced by Newsclick Team,
Veteran scientist Satyajit Rath talks about the differences, usefulness and the pros and cons of small and big molecules as constituents of drugs.

Finding drugs for diseases has been an age-old practice that humanity has been involved in. But with time, the pattern of drug molecules has changed. Medical research is slowly shifting towards relying more on large molecules, even as drugs from earlier days were more focused on the small molecules. The shifting trend, however, hasn’t been able to replace the small molecules completely as potential drug molecules. Veteran scientist Satyajit Rath talks about the differences, usefulness and the pros and cons of small and big molecules as constituents of drugs.

Get the latest reports & analysis with people's perspective on Protests, movements & deep analytical videos, discussions of the current affairs in your Telegram app. Subscribe to NewsClick's Telegram channel & get Real-Time updates on stories, as they get published on our website.

Subscribe Newsclick On Telegram

Latest